SI-BONE reports 3Q18 revenue of $13.4MM, +14.5% vs. 3Q17

SI-BONE, a pioneer of a minimally invasive surgical treatment for sacroiliac joint dysfunction using their iFuse implant system, posted 3Q18 revenue of US $13.4MM, +14.5% vs. 3Q17. This marks the first quarter for SI-BONE as a public company after the successful completion of their October 16, 2018 IPO that raised a net $113.7MM. The public...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us